Related Experiment Video
Updated: Mar 25, 2026

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
Brain MR Imaging Findings of Cardiac-Type Fabry Disease with an IVS4+919G>A Mutation
1From the Departments of Radiology (H.-J.L., S.-C.H., T.C.-M.) School of Medicine (H.-J.L., S.-C.H., T.-R.H., S.-C.K., T.C.-M., C.-C.H., D.-M.N., C.-P.L.).
Insights
Taiwanese patients with IVS4 Fabry disease show brain imaging features similar to classic Fabry disease, including increased white matter hyperintensities, infarctions, and pulvinar signs compared to controls.
Area of Science:
- Neurology
- Genetics
- Radiology
Background:
- A specific cardiac variant of Fabry disease, IVS4 + 919 G>A, is prevalent in Taiwan.
- Neurologic manifestations of this cardiac variant are not well understood.
Purpose of the Study:
- To investigate the neuroimaging features of IVS4-type Fabry disease.
- To compare these features with classic Fabry disease and healthy controls.
Main Methods:
- Retrospective analysis of 26 patients with IVS4 Fabry disease and 26 matched healthy controls.
- Assessment of white matter hyperintensities (WMH), pulvinar sign, and basilar artery diameter using MRI.
- Quantification of WMH volume.
Main Results:
- Infarctions were observed in 35% of IVS4 Fabry disease patients versus 0% of controls (P=.001).
- The pulvinar sign was present in 30% of IVS4 Fabry disease patients versus 0% of controls (P=.002).
- Patients with IVS4 Fabry disease had significantly higher deep white matter hyperintensity volume than controls (P=.004).
Conclusions:
- IVS4-type Fabry disease shares neuroimaging similarities with classic Fabry disease.
- This variant presents with a higher frequency of deep white matter hyperintensities, infarctions, and pulvinar signs compared to healthy individuals.
Background And Purpose:
A high incidence of cardiac-type Fabry disease with an α-galactosidase A mutation, IVS4 + 919 G>A, has been identified in the Taiwanese population. The neurologic manifestation has not been understood in this specific cardiac variant. This study aimed to investigate the typical imaging features of classic Fabry disease in patients with IVS4 Fabry disease.
Materials And Methods:
Twenty-six patients with IVS4-type Fabry disease (20 men and 6 women; age range, 43-71 years; median age, 61 years) and 26 age- and sex-matched healthy controls (age range, 44-68 years; median age, 60 years) were analyzed for white matter hyperintensities, the pulvinar sign, and basilar artery diameter. The volumes of white matter hyperintensities were calculated by comparison with an in-house data base of 276 controls.
Results:
Infarctions were found in 9 patients with IVS4 Fabry disease (35%) and in none of the healthy controls (P = .001). A pulvinar sign was found in 8 patients with IVS4 Fabry disease (30%) and in none of the healthy controls (P = .002). No significant difference was found in Fazekas scale scores for white matter hyperintensities; however, white matter hyperintensity volume in the deep white matter was higher in patients with IVS4 Fabry disease than in those from the healthy control data base (P = .004).
Conclusions:
Along with its involvement of the cardiac system, IVS4-type Fabry disease has features similar to those of classic Fabry disease and a higher frequency of deep white matter hyperintensities and a higher incidence of infarctions and pulvinar signs than in healthy controls.
More Related Videos
12:24Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Related Concept Videos
Imaging Studies for Cardiovascular System IV: CMRI
Magnetic Resonance Imaging
Cardiomyopathy IV: Restrictive Cardiomyopathy
Imaging Studies for Cardiovascular System V: CT
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy